Last reviewed · How we verify
NCT06311539
The Effect of Circadian Rhythm on Physical Performance in Healthy Male Individuals
NA trial testing Theraband Strengthening Exercise Program in Chronotype in 60 participants. Status unknown.
1 August 2024
Quick facts
| Lead sponsor | Istanbul Bilgi University |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | screening |
| Enrollment | 60 |
| Start date | 1 April 2024 |
| Primary completion | 1 August 2024 |
| Estimated completion | 1 October 2024 |
Drugs / interventions tested
- Theraband Strengthening Exercise Program
Conditions studied
- Chronotype — all drugs for Chronotype →
- Exercise — all drugs for Exercise →
Sponsor
Istanbul Bilgi University
Who can join
Adults 18 to 30, male only, with Chronotype or Exercise. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Little is known about optimizing the timing of exercise periods to maximize the health benefits of exercise. Furthermore, exercise is a potent modulator of skeletal muscle metabolism and it is clear that skeletal muscle has a robust circadian profile. Circadian rhythms can be observed in behavior, physiology, and metabolism. Various studies show that exercise changes the rhythm of the clock machines in skeletal muscle. Studies examining the relationship between exercise, especially strength training, and circadian rhythm are quite limited in the literature. Although some studies have shown that force peaks in the afternoon/evening hours, regardless of muscle group and contraction speed, there are no studies on how much this time interval varies from person to person and chronotype. The aim of this study is to investigate to what extent strength training given at appropriate times for morning, evening and intermediate chronotypes creates changes in performance in healthy adult male individuals.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06311539
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Chronotype
Currently open trials in the same condition.
- NCT06981702 — Effects of Exercıse on Chronotype, Sleep Qualıty and Depressıon Symptom Level in Unıversıty Students · NA · active not recruiting
- NCT06949371 — Investigation of the Effects of Chronotype Differences on Balance and Muscle Strength in Young Adults · NA · active not recruiting
Other Istanbul Bilgi University trials
Trials by the same sponsor.
- NCT06800144 — Effect of Music Therapy on Pain in People With Multiple Sclerosis · NA · recruiting
- NCT06847763 — The Long Term Effects of Online Therapeutic Neuroscience Education in Patients With Chronic Low Back Pain · NA · recruiting
- NCT07293624 — Effects of the Dietary Inflammatory Index on Systemic Inflammation Markers and Gastrointestinal Symptoms in Individuals · enrolling by invitation
- NCT07004478 — Turkish Adaptation Study of the Generic Functional Index · recruiting
- NCT07114341 — Effect of Lyophilized Cornelian Cherry on Anaerobic Performance in Young Football Players · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06311539 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Istanbul Bilgi University
- Last refreshed: 15 March 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06311539.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing